Schrodinger News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.11.24	Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference (Businesswire)
18.11.24	Schrödinger Broadens and Accelerates Predictive Toxicology Initiative (Businesswire)
12.11.24	Schrödinger Reports Third Quarter 2024 Financial Results (Businesswire)
12.11.24	Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis (Businesswire)
11.11.24	Ausblick: Schrodinger legt Zahlen zum jüngsten Quartal vor (finanzen.net)
04.11.24	Schrödinger to Present at Jefferies London Healthcare Conference (Businesswire)
31.10.24	Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 (Businesswire)
18.09.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
16.08.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
14.08.24	Schrödinger to Present at Morgan Stanley Global Healthcare Conference (Businesswire)
31.07.24	Schrödinger Reports Strong Second Quarter 2024 Financial Results (Businesswire)
30.07.24	Ausblick: Schrodinger veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
26.07.24	Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology (Businesswire)
17.07.24	Schrödinger to Announce Second Quarter 2024 Financial Results on July 31 (Businesswire)
16.07.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
11.07.24	What Analysts Are Saying About Schrodinger Stock (Benzinga)
14.06.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
22.05.24	Schrödinger to Present at Jefferies Global Healthcare Conference (Businesswire)
17.05.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
30.04.24	Ausblick: Schrodinger mit Zahlen zum abgelaufenen Quartal (finanzen.net)
18.04.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
16.04.24	Erste Schätzungen: Schrodinger stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
10.04.24	Schrödinger to Announce First Quarter 2024 Financial Results on May 1 (Businesswire)
20.03.24	Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting (Businesswire)
19.03.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
01.03.24	Critical Insights From Schrodinger Analyst Ratings: What You Need To Know (Benzinga)
27.02.24	Ausblick: Schrodinger gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
20.02.24	Schrödinger to Participate in Upcoming Investor Conferences (Businesswire)
16.02.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
14.02.24	Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28 (Businesswire)
13.02.24	Erste Schätzungen: Schrodinger stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
26.01.24	Key Takeaways From Schrodinger Analyst Ratings (Benzinga)
19.01.24	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
19.12.23	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
14.12.23	Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event (Businesswire)
10.12.23	Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting (Businesswire)
17.11.23	Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
06.11.23	Schrödinger to Participate in Upcoming Investor Conferences (Businesswire)
02.11.23	Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting (Businesswire)
01.11.23	Schrödinger, Inc Q3 Loss Increases, but beats estimates (RTTNews)
01.11.23	Schrödinger Reports Third Quarter 2023 Financial Results (Businesswire)
31.10.23	Ausblick: Schrodinger legt Zahlen zum jüngsten Quartal vor (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Schrodinger Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten